MX2018003985A - Proteina lisosomal modificada y produccion de la misma. - Google Patents

Proteina lisosomal modificada y produccion de la misma.

Info

Publication number
MX2018003985A
MX2018003985A MX2018003985A MX2018003985A MX2018003985A MX 2018003985 A MX2018003985 A MX 2018003985A MX 2018003985 A MX2018003985 A MX 2018003985A MX 2018003985 A MX2018003985 A MX 2018003985A MX 2018003985 A MX2018003985 A MX 2018003985A
Authority
MX
Mexico
Prior art keywords
lysosomal protein
modified
protein
lysosomal
production
Prior art date
Application number
MX2018003985A
Other languages
English (en)
Inventor
Nordling Erik
Strömberg Patrik
Svensson Gelius Stefan
Original Assignee
Swedish Orphan Biovitrum Ab Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Swedish Orphan Biovitrum Ab Publ filed Critical Swedish Orphan Biovitrum Ab Publ
Publication of MX2018003985A publication Critical patent/MX2018003985A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/06Sulfuric ester hydrolases (3.1.6)
    • C12Y301/06013Iduronate-2-sulfatase (3.1.6.13)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y310/00Hydrolases acting on sulfur-nitrogen bonds (3.10)
    • C12Y310/01Hydrolases acting on sulfur-nitrogen bonds (3.10) acting on sulfur-nitrogen bonds (3.10.1)
    • C12Y310/01001N-Sulfoglucosamine sulfohydrolase (3.10.1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01076L-Iduronidase (3.2.1.76)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)

Abstract

Se desvela en el presente documento una proteína lisosomal modificada, métodos de preparación de una proteína lisosomal modificada y uso terapéutico de una proteína modificada tal. Además, se desvela en el presente documento un método de tratamiento de un mamífero afectado con una enfermedad de almacenamiento lisosomal. En particular, la presente divulgación se refiere a un método de preparación de una proteína lisosomal modificada, comprendiendo dicho método hacer reaccionar una proteína lisosomal glucosilada con un peryodato de metal alcalino y hacer reaccionar dicha proteína lisosomal con un borohidruro de metal alcalino durante un periodo de tiempo de no más de 2 h, modificándose así los restos de glucano de la proteína lisosomal y reduciéndose la actividad de la proteína lisosomal con respecto a los receptores de reconocimiento de glucanos.
MX2018003985A 2015-10-01 2016-09-30 Proteina lisosomal modificada y produccion de la misma. MX2018003985A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15187877 2015-10-01
PCT/EP2016/073452 WO2017055570A1 (en) 2015-10-01 2016-09-30 Modified lysosomal protein and production thereof

Publications (1)

Publication Number Publication Date
MX2018003985A true MX2018003985A (es) 2018-12-10

Family

ID=54252124

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018003985A MX2018003985A (es) 2015-10-01 2016-09-30 Proteina lisosomal modificada y produccion de la misma.

Country Status (12)

Country Link
US (1) US20180258408A1 (es)
EP (1) EP3356542A1 (es)
JP (1) JP2018535654A (es)
KR (1) KR20180055888A (es)
CN (1) CN108291246A (es)
AU (1) AU2016329442A1 (es)
BR (1) BR112018006278A2 (es)
CA (1) CA3000289A1 (es)
IL (1) IL258369A (es)
MX (1) MX2018003985A (es)
PH (1) PH12018500604A1 (es)
WO (1) WO2017055570A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA50746A (fr) 2017-10-02 2020-08-12 Denali Therapeutics Inc Protéines de fusion comprenant des enzymes d'enzymothérapie substitutive
WO2020047282A1 (en) * 2018-08-29 2020-03-05 University Of Copenhagen Lysosomal enzymes modified by cell based glycoengineering
WO2023196807A1 (en) * 2022-04-06 2023-10-12 Rutgers, The State University Of New Jersey Methods for treating lysosomal storage diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008252B2 (en) * 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
WO2008109677A2 (en) * 2007-03-06 2008-09-12 Saint Louis University Modified enzyme and treatment method
PT2970413T (pt) * 2014-04-01 2018-10-23 Swedish Orphan Biovitrum Ab Publ Sulfamidase modificada e sua produção

Also Published As

Publication number Publication date
IL258369A (en) 2018-05-31
PH12018500604A1 (en) 2018-10-01
BR112018006278A2 (pt) 2018-10-16
EP3356542A1 (en) 2018-08-08
AU2016329442A1 (en) 2018-05-10
US20180258408A1 (en) 2018-09-13
KR20180055888A (ko) 2018-05-25
CN108291246A (zh) 2018-07-17
JP2018535654A (ja) 2018-12-06
WO2017055570A1 (en) 2017-04-06
CA3000289A1 (en) 2017-04-06

Similar Documents

Publication Publication Date Title
MX2023001878A (es) Celulas modificadas geneticamente que comprenden un gen humano modificado de la region constante alfa del receptor de celulas t.
PH12018500604A1 (en) Modified lysosomal protein and production thereof
MX2020000387A (es) Método general y directo para preparar nanopartículas de estructura organometálica funcionalizadas con oligonucleotidos.
MY190034A (en) Method of treating cancer associated with a ras mutation
MX2017007373A (es) Sistema de horma para calzado trenzado.
TW201614068A (en) Fucosidase from bacteroides and methods using the same
MX2018004831A (es) Metodos para confeccionar formas fucosiladas y afucosiladas de una proteina.
MX351508B (es) Sistemas y métodos para el diseño y fabricación de calzado de protección de pacientes.
IN2015DN03220A (es)
ZA202106779B (en) Process for producing agglomerated lignin and use thereof
PH12016501812A1 (en) Modified sulfamidase and production thereof
AU2016237099B2 (en) Method for producing novel nitrogen-containing compound or salt thereof, and production intermediate of same
NZ725398A (en) Variants of chymosin with improved milk-clotting properties
MX2011012505A (es) Piperidinas sustituidas.
GB201110777D0 (en) Methods and uses
MX2018000275A (es) Un proceso para tratar leche.
MX370156B (es) Composición y proceso para moldear o modificar la forma del cabello.
PH12017501304A1 (en) Levodopa and carbidopa intestinal gel and method of use
MX2018005322A (es) Composicion dermocosmetica, proceso de produccion de la composicion topica, metodo para fortalecer la fragilidad de las uñas y uso de la composicion.
MX2013011153A (es) Metodo para el analisis de conformacion por presion.
MX2011012507A (es) Piperidinas sustituidas.
MX2018014229A (es) Metodo para la produccion de plantas haploides y haploides duplicadas posteriores.
PL3152313T3 (pl) Sposób wytwarzania, w szczególności etanolu, przez sekwencyjną enzymatyczną hydrolizę celulozy i hemiceluloz surowców lignocelulozowych
CA2853848C (en) Process for producing a lubricant from an epoxy-triglyceride
CN205124886U (zh) 一种家禽吊挂装置